Generate Biomedicines, Inc. Common Stock (GENB) News

Latest headlines that mention GENB, newest first · each headline opens the original publisher

GENB quote

Last price: $12.35
Day change: -0.48%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

GENB headlines

latest coverage

Seeking Alpha News 12d ago

Generate Biomedicines: Zealand Deal For Obesity Programs May Not Be Quite What It Seems

General T2GENB

Investing.com 13d ago

Generate Biomedicines, Zealand Pharma form AI drug partnership

General T3GENB

Seeking Alpha News 13d ago

Generate Biomedicines: The Dosing Interval Is The Moat, Not The Algorithm

General T2GENB

Seeking Alpha News 1mo ago

Generate Biomedicines, Inc. (GENB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2GENB

Investing.com 1mo ago

Generate Biomedicines at Cantor healthcare conference: pipeline gains traction

General T3GENB

Investing.com 1mo ago

Generate Biomedicines stock price target raised to $30 by H.C. Wainwright on asthma data

General T3GENB

Seeking Alpha 2mo ago

Generate Biomedicines surges again, rises 12% to new high

General T2GENB

Yahoo Finance 2mo ago

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

IPO T2GENB

Motley Fool 2mo ago

This Is Nvidia CEO Jensen Huang's Favorite Biotech Stock -- and You've Probably Never Heard of It

Generate Biomedicines focuses on AI-enabled drug discovery.

Tech T3GENB NVDA

Seeking Alpha News 3mo ago

Generate Biomedicines: Post Mega-Money IPO, Caution Is Warranted

IPO T2GENB

Yahoo Finance 4mo ago

Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

General T2GENB MS

Seeking Alpha 5mo ago

Generate Biomedicines, Inc. reports Q1 results

Earnings T2GENB

GENB news alerts

Get an alert by email or push when a new headline mentions GENB.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.